Literature DB >> 32423274

Global Burden of Chronic Respiratory Diseases.

Giovanni Viegi1,2, Sara Maio2, Salvatore Fasola1, Sandra Baldacci2.   

Abstract

Background: Noncommunicable diseases (NCDs) and chronic respiratory diseases (CRDs) are the main causes of mortality and morbidity worldwide.
Methods: The main evidences about the NCDs and CRDs burden and related risk factors, from updated international reports and results of original researches, were collected and described in this review.
Results: Most recent evidence is available from the Global Burden of Diseases Study (GBD) 2017 reports. There were 3.2 million deaths due to chronic obstructive pulmonary disease (COPD) and 495,000 deaths due to asthma. COPD was the seventh leading cause of years of life lost (YLLs). Overall, prevalent cases of CRDs were 545 million: about 50% for COPD and 50% for asthma. Incident cases of CRDs were 62 million, mostly due to asthma (69%) and COPD (29%). COPD accounted for 81.6 million disability-adjusted life years, asthma for 22.8 million. COPD prevalence of 9.1% has been found in a recent general population sample of North-Eastern Italy, while in Central Italy a 25-year follow-up of a general population sample has shown an increased prevalence of COPD and asthma up to 6.8% and 7.8%, respectively. In Central Italy, a COPD incidence of 8% and an asthma incidence of 3.2% have been found in adult subjects at an 18-year follow-up. Among the risk factors, a relevant role is played by smoking and high body mass index for asthma, while smoking, particulate matter pollution, ambient ozone pollution, occupational exposure to particulate matter, gases and fumes, as well as second-hand smoke, play an important role for COPD. Forecasting the YLLs by 2040 indicates a rising toll from several NCDs due to population growth and aging, with COPD expected to reach the fourth leading cause. Conclusions: Several recent studies and international reports highlighted the huge global health burden of CRDs and other major NCDs, pointing out the need for implementing international collaborations to fight this epidemic trend.

Entities:  

Keywords:  COPD; asthma; deaths; disability-adjusted life years; incidence; prevalence; risk factors; years lived with disability

Mesh:

Year:  2020        PMID: 32423274     DOI: 10.1089/jamp.2019.1576

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  20 in total

Review 1.  A systematic review and meta-analysis of homocysteine concentrations in chronic obstructive pulmonary disease.

Authors:  Angelo Zinellu; Elisabetta Zinellu; Maria Carmina Pau; Alessandro G Fois; Sabrina Mellino; Barbara Piras; Valentina Scano; Sara S Fois; Arduino A Mangoni; Ciriaco Carru; Pietro Pirina
Journal:  Clin Exp Med       Date:  2022-05-05       Impact factor: 5.057

2.  Extracorporeal membrane oxygenation-the good, the bad and the ugly (for want of a "few dollars more"): and would "a fistful of dollars" make any difference?

Authors:  Thirugnanasambandan Sunder
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-03-29

3.  Enhanced delivery of peptide-morpholino oligonucleotides with a small molecule to correct splicing defects in the lung.

Authors:  Yan Dang; Catharina van Heusden; Veronica Nickerson; Felicity Chung; Yang Wang; Nancy L Quinney; Martina Gentzsch; Scott H Randell; Hong M Moulton; Ryszard Kole; Aiguo Ni; Rudolph L Juliano; Silvia M Kreda
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

Review 4.  GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting.

Authors:  Barbara P Yawn; Matthew L Mintz; Dennis E Doherty
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-12

Review 5.  Neuroimmune regulatory networks of the airway mucosa in allergic inflammatory disease.

Authors:  E Evonne Jean; Olivia Good; Juan M Inclan Rico; Heather L Rossi; De'Broski R Herbert
Journal:  J Leukoc Biol       Date:  2021-04-15       Impact factor: 6.011

Review 6.  How to Choose the Right Inhaler Using a Patient-Centric Approach?

Authors:  Didier Cataldo; Shane Hanon; Rudi V Peché; Daniel J Schuermans; Jean M Degryse; Isabelle A De Wulf; Karin Elinck; Mathias H Leys; Peter L Rummens; Eric Derom
Journal:  Adv Ther       Date:  2022-01-26       Impact factor: 3.845

7.  Relationship between Multimorbidity and Quality of Life in a Primary Care Setting: The Mediating Role of Dyspnea.

Authors:  Pietro Alfano; Giuseppina Cuttitta; Palma Audino; Giovanni Fazio; Sabina La Grutta; Salvatore Marcantonio; Salvatore Bucchieri
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

Review 8.  Drosophila Trachea as a Novel Model of COPD.

Authors:  Aaron Scholl; Istri Ndoja; Lan Jiang
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

9.  Association Between Vitamin D Levels and FEV1, Number of Exacerbations, and CAT Score in Stable COPD Patients in Indonesia.

Authors:  Arto Yuwono Soeroto; Dadan Setiawan; Nabila Nauli Asriputri; Guntur Darmawan; Geraldo Laurus; Prayudi Santoso
Journal:  Int J Gen Med       Date:  2021-10-28

10.  Primary care for people with severe mental illness and comorbid obstructive airways disease: a qualitative study of patient perspectives with integrated stakeholder feedback.

Authors:  Caroline Mitchell; Nicholas Zuraw; Brigitte Delaney; Helen Twohig; Neil Dolan; Elizabeth Walton; Joe Hulin; Camelia Yousefpour
Journal:  BMJ Open       Date:  2022-03-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.